Dosage and administration
Take wipe and rub thoroughly over all surfaces of both hands,Rub hands together briskly to dry .Dispose of wipe.
Take wipe and rub thoroughly over all surfaces of both hands,Rub hands together briskly to dry .Dispose of wipe.
Benzalkonium chloride 0.13%
Antibacterial
For hand sanitizing to decrease bacteria on the skin
recommended for repeated use
For external use only.
When useing this product avoid contact with eyes.In case of eye contact,flush eyes with water.
Stop use and ask a doctor if irritation or redness develops.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
if swallowed
get medical help or contact a Poison Control Center right away.
Take wipe and rub thoroughly over all surfaces of both hands,Rub hands together briskly to dry .Dispose of wipe.
Purified Water ,Glycerin,Aloe Barbadensis Leaf Juice,Anionic surfactant.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1038558 | benzalkonium chloride 0.13 % Medicated Pad | PSN | 2 |
| 1038558 | benzalkonium chloride 1.3 MG/ML Medicated Pad | SCD | 2 |
| 1038558 | benzalkonium chloride 0.13 % Topical Cloth | SY | 2 |
| 1038558 | benzalkonium chloride 0.13 % Topical Swab | SY | 2 |
| 1038558 | benzalkonium chloride 0.13 GM per 100 GM Topical Pad | SY | 2 |
| 1038558 | benzalkonium chloride 0.13 GM per 100 GM Topical Swab | SY | 2 |
| 1038558 | benzalkonium chloride 1 ML per 750 ML Topical Swab | SY | 2 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61312-001-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-04 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-06 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-07 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-08 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-09 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-11 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| 61312-001-12 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ec93-f424-e053-dadaa90a57ce | 001 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61312-001-01 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-01 | Hand Sanitizing wipes | 10 in 1 BOTTLE | SWAB | 10 | 2 | |
| 61312-001-02 | Hand Sanitizing wipes | 25 in 1 BOTTLE | SWAB | 25 | 2 | |
| 61312-001-02 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-03 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-03 | Hand Sanitizing wipes | 40 in 1 BOTTLE | SWAB | 40 | 2 | |
| 61312-001-04 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-04 | Hand Sanitizing wipes | 60 in 1 BOTTLE | SWAB | 60 | 2 | |
| 61312-001-05 | Hand Sanitizing wipes | 100 in 1 BOTTLE | SWAB | 100 | 2 | |
| 61312-001-05 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-06 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-06 | Hand Sanitizing wipes | 120 in 1 BOTTLE | SWAB | 120 | 2 | |
| 61312-001-07 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-07 | Hand Sanitizing wipes | 200 in 1 BOTTLE | SWAB | 200 | 2 | |
| 61312-001-08 | Hand Sanitizing wipes | 240 in 1 BOTTLE | SWAB | 240 | 2 | |
| 61312-001-08 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-09 | Hand Sanitizing wipes | 250 in 1 BOTTLE | SWAB | 250 | 2 | |
| 61312-001-09 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-10 | Hand Sanitizing wipes | 800 in 1 BOTTLE | SWAB | 800 | 2 | |
| 61312-001-10 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-11 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 | |
| 61312-001-11 | Hand Sanitizing wipes | 1200 in 1 BOTTLE | SWAB | 1200 | 2 | |
| 61312-001-12 | Hand Sanitizing wipes | 1500 in 1 BOTTLE | SWAB | 1500 | 2 | |
| 61312-001-12 | Hand Sanitizing wipes | 0.00468 g in 1 POUCH | SWAB | 0.00468 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BENZALKONIUM CHLORIDE | ACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| BENZALKONIUM | ACTIVE MOIETY | 7N6JUD5X6Y | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| SODIUM DODECYLBENZENESULFONATE | INACTIVE INGREDIENT | 554127163Y | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61312-001 | 61312-001-01, 61312-001-02, 61312-001-03, 61312-001-04, 61312-001-05, 61312-001-06, 61312-001-07, 61312-001-08, 61312-001-09, 61312-001-10, 61312-001-11, 61312-001-12 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| SODIUM DODECYLBENZENESULFONATE | 554127163Y | IACT |
| WATER | 059QF0KO0R | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6258b68a-7db0-1fe5-e053-2991aa0a9b1e | 6ec18dd8-864f-42da-85f1-41e38afbcc18 | 2018-01-09 | Warnings | 6258b68a-7db0-1fe5-e053-2991aa0a9b1e 6ec18dd8-864f-42da-85f1-41e38afbcc18 |
Adverse event summaries are temporarily unavailable. Other product information remains available.